[go: up one dir, main page]

IT8823075A0 - Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni - Google Patents

Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni

Info

Publication number
IT8823075A0
IT8823075A0 IT8823075A IT2307588A IT8823075A0 IT 8823075 A0 IT8823075 A0 IT 8823075A0 IT 8823075 A IT8823075 A IT 8823075A IT 2307588 A IT2307588 A IT 2307588A IT 8823075 A0 IT8823075 A0 IT 8823075A0
Authority
IT
Italy
Prior art keywords
total
active ingredients
pharmaceutical active
partial coating
related compositions
Prior art date
Application number
IT8823075A
Other languages
English (en)
Other versions
IT1227899B (it
Inventor
Achille Fiori
Alberto Natali
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Priority to IT8823075A priority Critical patent/IT1227899B/it
Publication of IT8823075A0 publication Critical patent/IT8823075A0/it
Priority to DE3943242A priority patent/DE3943242A1/de
Priority to FR8917074A priority patent/FR2670112A1/fr
Application granted granted Critical
Publication of IT1227899B publication Critical patent/IT1227899B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
IT8823075A 1988-12-23 1988-12-23 Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni IT1227899B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT8823075A IT1227899B (it) 1988-12-23 1988-12-23 Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
DE3943242A DE3943242A1 (de) 1988-12-23 1989-12-22 Vollstaendiger oder partieller ueberzug von pharmazeutischen wirkstoffen und entsprechende zusammensetzungen
FR8917074A FR2670112A1 (fr) 1988-12-23 1989-12-22 Enrobage total ou partiel de principes actifs pharmaceutiques et compositions correspondantes.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8823075A IT1227899B (it) 1988-12-23 1988-12-23 Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni

Publications (2)

Publication Number Publication Date
IT8823075A0 true IT8823075A0 (it) 1988-12-23
IT1227899B IT1227899B (it) 1991-05-14

Family

ID=11203507

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8823075A IT1227899B (it) 1988-12-23 1988-12-23 Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni

Country Status (3)

Country Link
DE (1) DE3943242A1 (it)
FR (1) FR2670112A1 (it)
IT (1) IT1227899B (it)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1252185B (it) * 1991-12-11 1995-06-05 Therapicon Srl Preparazioni farmaceutiche a liberazione programmata
FR2725623A1 (fr) * 1994-10-18 1996-04-19 Flamel Tech Sa Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
IN191482B (it) * 1999-03-19 2003-12-06 Ranbaxy Lab Ltd
AU1169601A (en) * 1999-11-16 2001-05-30 Ranbaxy Laboratories Limited Taste masked oral compositions
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
AP1748A (en) 2001-03-13 2007-06-11 Penwest Pharmaceuticals Co Chronotherapeutic dosage forms.
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US7906145B2 (en) 2002-04-09 2011-03-15 Flamel Technologies Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
CN100577164C (zh) 2002-04-09 2010-01-06 弗拉梅技术公司 可改进释放阿莫西林的微囊含水混悬液形式的口服药物制剂
FR2843881B1 (fr) * 2002-09-02 2006-06-02 Flamel Tech Sa Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
FR2842735B1 (fr) * 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
GB0320522D0 (en) 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
EP1670442A4 (en) 2003-09-19 2011-09-14 Penwest Pharmaceuticals Co DOSAGE FORMS WITH DELAYED RELEASE
FR2862536B1 (fr) 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
DE102005024614A1 (de) * 2005-05-25 2006-11-30 Röhm Gmbh Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
KR101506627B1 (ko) * 2013-12-26 2015-03-30 현대약품 주식회사 아세브로필린 및 친수성 서방기제를 포함하는 서방형 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
DE3712058A1 (de) * 1987-04-09 1988-10-20 Boehringer Ingelheim Kg Theophyllinhaltige pharmazeutische formen

Also Published As

Publication number Publication date
FR2670112A1 (fr) 1992-06-12
DE3943242A1 (de) 1990-06-28
IT1227899B (it) 1991-05-14

Similar Documents

Publication Publication Date Title
IT8823075A0 (it) Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
IT8719081A0 (it) Complessi di bioflavonoidi con fosfolipidi, loro preparazione, uso e composizioni farmaceutici e cosmetiche.
IT8721253A0 (it) Composizioni farmaceutiche e cosmetiche contenenti complessi di flavonolignani con fosfolipidi.
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
FI960032L (fi) Farmaseuttisia koostumuksia vaikeasti liukenevia aktiiviaineita varten
IT8519873A0 (it) Procedimento di solubilizzazione di principi attivi e composizioni farmaceutiche cosi' ottenute.
MX163955B (es) Composicion farmaceutica de dihidrocodeina e ibuprofen
IT8521603A0 (it) Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi.
IT8820073A0 (it) Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
ITRM910189A0 (it) Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono
AU3386589A (en) Acid addition salts of tauro- and glycochlolic acid and their use in pharmaceutical compositions
ES2023286B3 (es) Composicion cosmetica o farmaceutica de uso cutaneo y procedimiento para la preparacion de tal composicion
IT1224574B (it) Fattore di attivazione di leucociti neutrofili, procedimento di preparazione, nonche' composizioni farmaceutiche che lo contengono
BR9406747A (pt) Uso de um composto compostos processos de preparação dos mesmos de inibição da ação de enzimas e de tratamento ou profilaxia de doença cardiovascular e formulação farmacêutica
IT1297205B1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
DK439589D0 (da) Fluorsubstituerede 4'-demethylepipodophyllotoksinderivater samt farmaceutiske praeparater indeholdende samme
IL67925A0 (en) Laevorotatory isomer of mequitazine,its preparation and pharmaceutical compositions containing it
IT1229223B (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
IT9048102A0 (it) Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
IT8521528A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo.
IT8547765A1 (it) Derivato di cefalosporina composizione farmaceutica che lo contiene e relativo procedimento di preparazione ed applicazione
IT8619288A0 (it) Formulazioni farmaceutiche iniettabili di principi attivi adattivita' anestetica generale.
IT8619832A1 (it) Acilamminoalcanoil uretani o tiouretani utili quali analgesici e relative composizioni farmaceutiche
IT8922446A0 (it) Procedimento per la preparazione di primicina idrosolubile e suoi componenti e composizioni farmaceutiche che li contengono
IT1191986B (it) Derivati naftalenici di benzonorbornene loro procedimento di preparazione e composizioni farmaceutiche e cosmetiche che li contengono

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 2

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 2, 19911211; POLI INDUSTRIA CHIMICA S.P.A.

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19931230